- Trials with a EudraCT protocol (41)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
41 result(s) found for: Gonadotropins.
Displaying page 1 of 3.
| EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
| Sponsor Name:IVI Madrid | ||
| Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
| Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003556-20 | Sponsor Protocol Number: 1806-LIS-044-SD | Start Date*: 2019-06-17 |
| Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDADE - CLÍNICA DE REPRODUÇÃO ASSISTIDA, LDA | ||
| Full Title: How do different ovarian stimulation protocols affect endometrial receptivity during a fresh in vitro fertilization attempt? | ||
| Medical condition: Women with a clinical indication to undergo Assisted Reproductive Technologies for infertility with a predicted normal response to Ovarian Stimulation and planned for a single blastocyst transfer | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: PT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004114-99 | Sponsor Protocol Number: FERTIRES-2016 | Start Date*: 2017-05-18 |
| Sponsor Name:AB-BIOTICS | ||
| Full Title: USE OF P.N680S POLYMORPHISM TO CHOOSE THE EXOGEN FSH DOSE IN CONTROLLED OVARIAN HYPERSTIMULATION: A PROSPECTIVE TRIAL | ||
| Medical condition: Infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004495-36 | Sponsor Protocol Number: M90-516 | Start Date*: 2014-11-28 | |||||||||||
| Sponsor Name:Abbvie previously known as Abbott | |||||||||||||
| Full Title: Study of Lupron Depot in the Treatment of Central Precocious Puberty | |||||||||||||
| Medical condition: Central Precocious Puberty | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-000655-24 | Sponsor Protocol Number: CBG-study2 | Start Date*: 2015-04-28 | |||||||||||
| Sponsor Name:rigshospitalet | |||||||||||||
| Full Title: Denosumab and male infertility: a prospective intervention study | |||||||||||||
| Medical condition: Male infertility especially low sperm count | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-002310-16 | Sponsor Protocol Number: LHinPOR001 | Start Date*: 2023-02-01 |
| Sponsor Name:UZ Brussel | ||
| Full Title: Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders. | ||
| Medical condition: Infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006372-29 | Sponsor Protocol Number: BlockeelC | Start Date*: 2008-11-28 |
| Sponsor Name:Blockeel Christophe | ||
| Full Title: Among non-IVF patients undergoing ovulation induction with clomiphene citrate (Clomid® 50 mg) and having no reaction at day 13 of the cycle, does administration of an increased dose of clomiphene c... | ||
| Medical condition: The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induct... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-003412-31 | Sponsor Protocol Number: BROVALE-2012(BC-POF2012) | Start Date*: 2012-10-01 | |||||||||||||||||||||
| Sponsor Name:CUB - Hôpital Erasme | |||||||||||||||||||||||
| Full Title: Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients. | |||||||||||||||||||||||
| Medical condition: The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromat... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2007-004544-73 | Sponsor Protocol Number: 311623 | Start Date*: 2008-01-23 |
| Sponsor Name:Bayer Schering Pharma AG | ||
| Full Title: A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles | ||
| Medical condition: The trial will be performed in healthy female volunteers. The intended indication is female contraception. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-009177-10 | Sponsor Protocol Number: BAY86-5016/14348 | Start Date*: 2009-04-30 |
| Sponsor Name:Bayer HealthCare AG | ||
| Full Title: Multicenter, open-label, randomized study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in health... | ||
| Medical condition: The trial will be performed in healthy female volunteers. The intended indication is femal contraception. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-021195-28 | Sponsor Protocol Number: BAY 98-7161 / 14835 | Start Date*: 2011-02-25 |
| Sponsor Name:Bayer HealthCare AG | ||
| Full Title: Single-center, randomized, placebo-controlled, double-blind, parallel group study to evaluate whether a single-dose of either 20 mg piroxicam, 40 mg piroxicam or 80 mg piroxicam shows an effect on... | ||
| Medical condition: Emergency Contraception | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-001198-13 | Sponsor Protocol Number: 310805 | Start Date*: 2008-08-19 |
| Sponsor Name:Bayer HealthCare AG/Bayer Schering Pharma AG | ||
| Full Title: Multicenter, open-label, randomized, uncontrolled study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gesto... | ||
| Medical condition: The trial will be performed in healthy female volunteers. The indended indication is female contraception. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-002341-30 | Sponsor Protocol Number: 1705-VLC-030-JG | Start Date*: 2017-09-11 | |||||||||||
| Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI) | |||||||||||||
| Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization | |||||||||||||
| Medical condition: prevent premature luteinitation | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-007932-25 | Sponsor Protocol Number: 28091 | Start Date*: 2008-05-07 |
| Sponsor Name:Merck Lipha Santé | ||
| Full Title: A phase IIIb randomized open-label study to compare between IVF/ICSI outcomes two regimen of Cetrotide 0.25 mg used from Day 1 or from Day 7 of the menstrual cycle (Day 0 or Day 6 of stimulation) ... | ||
| Medical condition: Prevention of premature ovulation in polycystic ovarian women undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-001342-18 | Sponsor Protocol Number: IB-0319-001 | Start Date*: 2019-08-19 |
| Sponsor Name:Instituto Bernabeu | ||
| Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY | ||
| Medical condition: Suboptimal response of ovarian stimulation | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-002678-10 | Sponsor Protocol Number: GF22002 | Start Date*: 2023-03-07 |
| Sponsor Name:Ginefiv | ||
| Full Title: Protocol with progestin-primed ovarian stimulation (PPOS) starting on day 5 versus protocol with progestin-primed ovarian stimulation (PPOS) in a conventional regimen from the start of the ovaria... | ||
| Medical condition: Number of MII oocytes obtained in both groups | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000971-17 | Sponsor Protocol Number: 58335 | Start Date*: 2019-07-17 |
| Sponsor Name:UZ Brussel | ||
| Full Title: Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study | ||
| Medical condition: infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001338-32 | Sponsor Protocol Number: NFPA12 | Start Date*: 2012-09-24 | |||||||||||
| Sponsor Name:St. Olavs Hospital Trondheim University Hospital | |||||||||||||
| Full Title: Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) - a randomized controlled trial. The efficacy of cabergoline on tumour volume in previously untreated macroadenomas or resid... | |||||||||||||
| Medical condition: non-functioning pituitary adenomas | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NO (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-021255-81 | Sponsor Protocol Number: BAY 86-5016/15264 | Start Date*: 2010-09-13 | |||||||||||
| Sponsor Name:Bayer HealthCare AG | |||||||||||||
| Full Title: Multicenter, open-label, randomized study to evaluate inhibition of ovulation during treatment with three transdermal patch formulations containing 0.55 mg ethinylestradiol (EE) and 2.10 mg gestod... | |||||||||||||
| Medical condition: Prevention of Pregnancy | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-002612-52 | Sponsor Protocol Number: LUCAS | Start Date*: 2021-02-19 | ||||||||||||||||
| Sponsor Name:Department of Endocrinology, Rigshospitalet | ||||||||||||||||||
| Full Title: A randomized, double-blinded, clinical, placebo-controlled trial on the effects of therapy with Letrozole and hUman Choriongonadotropin in male hypogonadism induced by illicit use of Anabolic andro... | ||||||||||||||||||
| Medical condition: Male hypogonadism related to illicit use of anabolic androgenic steroids | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male | |||||||||||||||||
| Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
